综合性转录组分析发现长期非编码RNA失调以及阿片类药物使用障碍的奖励和执行电路的昼夜干扰
medRxiv : the preprint server for health sciences
|February 27, 2026
概括
长非编码RNAs (lncRNAs) 最近被确定为阿片类药物使用障碍 (OUD) 中的关键参与者. 这项研究揭示了大脑区域中广泛的lncRNA失调,影响神经免疫和突触通路,以及OUD中的昼夜节律.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 成研究 研究成研究
背景情况:
- 阿片类药物使用障碍 (OUD) 涉及强迫性寻找药物和受损的执行控制,与大脑电路不适应性可塑性有关.
- 之前的转录基因研究集中在奖励和执行区域的编码基因上,不清楚非编码基因组在OUD中的作用.
研究的目的:
- 系统地识别和表征OUD.个体的核突 (NAc) 和背侧前额皮层 (DLPFC) 中的长非编码RNA (lncRNAs).
- 研究非编码基因组,特别是lncRNAs对OUD病理生理学的贡献.
主要方法:
- 死亡后人类NAc和DLPFC组织的综合性转录基因分析.
- 识别和表征 lncRNA loci,包括新的注释.
- 分析 lncRNA 同表达模块及其对生物通路的丰富.
- 与单核转录组数据的整合,以评估细胞类型的特异性.
主要成果:
- 确定了36,225个lncRNA位点,其中大约一半以前没有被注释.
- 观察到与OUD相关的NAc和DLPFC中lncRNAs的广泛失调.
- 对神经免疫信号传递,突触通路和细胞内级联来说,lncRNA联合表达模块得到了丰富.
- OUD显著扰乱了 lncRNA 昼夜节律,相当于或超过mRNA 扰乱.
- 与OUD相关的lncRNAs显示出明显的神经元和质细胞类型特异性.
结论:
- lncRNAs代表了大脑的奖励和执行电路中的关键调节层.
- lncRNAs的失调,包括它们的空间,时间和细胞表达的改变,有助于OUD中的电路功能障碍.
- 这项研究强调了非编码基因组是成病理学的重要因素,为OUD研究和治疗目标开辟了新的途径.
相关概念视频
02:19Circadian Rhythms and Gene Regulation
4.6K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.6K
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.8K
3.8K
01:22Opioid Receptors: Overview
5.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.4K
01:25Analgesia and Pain Management
2.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
429
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
429